Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Lamei Pharmaceuticals: Supplemental application for injectable Amikacin approved
LaiMei Pharmaceutical Co., Ltd. Announcement: Recently, the Company received the “Approval Notice for a Supplemental Application for a Drug” issued and approved by the National Medical Products Administration for Amikacin for Injection (Specification: 1.0g). The drug is indicated for the treatment of infections caused by susceptible Gram-negative bacteria: urinary tract infections (uncomplicated and complicated), lower respiratory tract infections, sepsis, skin and skin structure infections, intra-abdominal infections, and gynecological infections.